The Elmet Group Co. filed a Form 8-K with the SEC on September 22, 2026, disclosing that on September 21, 2026, it entered into a warrant purchase agreement with Blue Moon Metals Inc. to issue an unregistered warrant to purchase up to 1,166,970 shares …
Henry Schein, Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing that on September 21, 2026, the company amended and restated its existing revolving credit agreement, increasing commitments from $1 billion to $1.25 billion and extending the termination date to …
CNX Resources Corporation filed a Form 8-K on September 22, 2026, reporting the departure of Chief Financial Officer Everett W. Good and the appointment of Ravi Srivastava as his successor, effective September 17, 2026.
Pentair plc filed a Form 8-K on September 22, 2026, disclosing the appointment of Robert W. Hau as Executive Vice President and Chief Financial Officer, effective November 1, 2026, at which time Interim CFO Robert P. Fishman will resign from that role.
U.S. GoldMining Inc. filed a Form 8-K on September 22, 2026, disclosing the completion of its 2026 drill program targeting high-priority porphyry centers at its Whistler Gold-Copper Project in Alaska.
Circle Internet Group, Inc. filed a Form 8-K on September 22, 2026, disclosing a five-year expanded commercial arrangement with Binance and a concurrent private placement of Class A common stock to Binance for aggregate proceeds of $100 million.
AutoZone, Inc. filed a Form 8-K on September 22, 2026, disclosing that it issued a press release announcing earnings for the fiscal quarter ended August 29, 2026.
Cognex Corporation filed a Form 8-K with the SEC on September 22, 2026, disclosing a definitive agreement to acquire RealSense, Inc. in an all-cash transaction valued at $500 million.
Cypherpunk Technologies Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing the appointment of Amanda Fabiano as a Class III director on the company's Board of Directors, effective immediately.
Lexeo Therapeutics, Inc. filed an 8-K with the SEC on September 22, 2026, disclosing that it entered into an Agreement and Plan of Merger with Mantle Therapeutics Inc. on September 16, 2026, under which Mantle would become a wholly owned subsidiary of Lexeo.